Cancer stem cells needed for metastatic growth
Researchers from Ludwig-Maximilians-University in Munich have determined that cancer stem cells govern metastasis in pancreatic cancer as well as making tumors resistant to chemotherapy. Patrick Hermann and colleagues focused specifically on pancreatic cancer, but scientists in the field say that it's a validation of other research that has identified a specific set of stem cells as playing a pivotal role in advancing a variety of cancers. Cancer stem cells are characterized by the cell surface antigen CD133. A subset of CD133 cells formed tumors and metastases when injected into mice. Compounds that attack these specific cells could play a big role in future anti-cancer therapies.
- read the article from The Scientist
Be the first to comment Rate it:
Comments
Post new comment
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

